A firestorm erupted this week in response to the pharmaceutical company Mylan’s sharp increase in the price of its EpiPen, a life-saving treatment for severe allergic reactions. The company quickly backtracked, announcing a rebate plan. Here, three Northeastern faculty members—pharmacist Tayla Rose, healthcare finance expert Steven Pizer, and health policy researcher Gary Young—explain the clinical, economic, and policy implications of the controversy.
The Office of Institutional Diversity and Inclusion on Wednesday presented to the Faculty Senate an overview of the office’s goals to increase the number of underrepresented minorities working and studying on campus.
On Wednesday, university administrators and faculty members discussed the planned changes for employees’ medical plan options and pledged to improve communication in light of concerns that have arisen from the process.
Northeastern graduate students design a strategy to expand the impact of a mobile clinic offering Boston residents free health screenings and coaching.
In his new book, Northeastern academic dean says stakeholders in the U.S. health care system will reap real benefits by working together